Baidu
map

Nano Lett:新型评价肿瘤化疗疗效的分子成像技术现曙光

2016-04-15 王磊 杨保国 中国青年报

近日

近日,中国科学技术大学化学与材料科学学院梁高林教授课题组与中科院强磁场科学中心钟凯研究员课题组合作,发明一种能在化疗肿瘤内“智能”自聚集的磁共振纳米造影剂,并在患肿瘤的小鼠体内验证了其优异肿瘤成像效果。该研究成果3月31日在线发表在国际著名学术期刊《纳米快报》上。

半胱天冬酶家族在介导细胞凋亡的过程中起着重要的作用,对半胱天冬酶的检测可以很好地监测肿瘤细胞的早期凋亡,从而评价肿瘤化疗的疗效,为后续治疗提供参考。核磁共振成像是一种无放射、非侵入的影像学技术,且成像参数多、扫描速度快、组织分辨率高,是常见的影像检查方式。磁性纳米粒子在生物成像方面已经得到广泛应用,大的磁性纳米粒子比目前常用的小磁性氧化铁纳米粒子在磁共振成像方面更具优越性,但前者在血液中被很快清除,导致组织的磁共振信号降低。

为解决这一难题,梁高林教授课题组设计了一种“智能”小分子——四氧化三铁复合纳米粒子,该纳米粒子在凋亡肿瘤细胞内半胱天冬酶的控制下,“智能”地自聚集成大尺寸磁性纳米粒子,可显著增强肿瘤的横向磁共振成像信号。他们与钟凯课题组合作,在中科院强磁场科学中心9.4特斯拉磁场强度下对小鼠肿瘤活体进行磁共振成像,结果显示,与对照组四氧化三铁磁性纳米粒子相比,该“智能”四氧化三铁磁性纳米粒子的横向加权磁共振成像信号显著增强,并且没有对小鼠产生毒性。

专家称,这种新型的四氧化三铁磁共振纳米造影剂,能够更加简单、准确和灵敏地测定体内外半胱天冬酶的活性,从而为肿瘤化疗疗效评价提供了新思路。审稿人高度评价了这一新颖的策略,称“这个新方法提供了一个很有价值的生物标志物用于肿瘤的成像和抗癌治疗疗效的检测”。

原始出处:

Yuan Y, Ding Z, Qian J, Zhang J, Xu J, Dong X, Han T, Ge S, Luo Y, Wang Y, Zhong K, Liang G. Casp3/7-Instructed Intracellular Aggregation of Fe3O4 Nanoparticles Enhances T2 MR Imaging of Tumor Apoptosis. Nano Lett. 2016 Apr 13;16(4):2686-91

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1725136, encodeId=ebcf1e2513609, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Apr 25 10:47:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444144, encodeId=99a71444144fe, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sun Apr 17 09:47:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570735, encodeId=595315e0735b5, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Sun Apr 17 09:47:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78785, encodeId=f9bbe8785a2, content=能生物治疗吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160412/IMG570C62AB017373724.jpg, createdBy=f6b41705718, createdName=Wechat4343a314, createdTime=Sat Apr 16 19:50:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78754, encodeId=54a3e8754ba, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sat Apr 16 17:30:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78755, encodeId=5655e8755e3, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sat Apr 16 17:30:00 CST 2016, time=2016-04-16, status=1, ipAttribution=)]
    2016-04-25 yangpeizhi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1725136, encodeId=ebcf1e2513609, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Apr 25 10:47:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444144, encodeId=99a71444144fe, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sun Apr 17 09:47:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570735, encodeId=595315e0735b5, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Sun Apr 17 09:47:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78785, encodeId=f9bbe8785a2, content=能生物治疗吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160412/IMG570C62AB017373724.jpg, createdBy=f6b41705718, createdName=Wechat4343a314, createdTime=Sat Apr 16 19:50:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78754, encodeId=54a3e8754ba, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sat Apr 16 17:30:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78755, encodeId=5655e8755e3, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sat Apr 16 17:30:00 CST 2016, time=2016-04-16, status=1, ipAttribution=)]
    2016-04-17 huagfeg
  3. [GetPortalCommentsPageByObjectIdResponse(id=1725136, encodeId=ebcf1e2513609, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Apr 25 10:47:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444144, encodeId=99a71444144fe, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sun Apr 17 09:47:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570735, encodeId=595315e0735b5, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Sun Apr 17 09:47:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78785, encodeId=f9bbe8785a2, content=能生物治疗吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160412/IMG570C62AB017373724.jpg, createdBy=f6b41705718, createdName=Wechat4343a314, createdTime=Sat Apr 16 19:50:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78754, encodeId=54a3e8754ba, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sat Apr 16 17:30:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78755, encodeId=5655e8755e3, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sat Apr 16 17:30:00 CST 2016, time=2016-04-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1725136, encodeId=ebcf1e2513609, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Apr 25 10:47:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444144, encodeId=99a71444144fe, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sun Apr 17 09:47:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570735, encodeId=595315e0735b5, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Sun Apr 17 09:47:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78785, encodeId=f9bbe8785a2, content=能生物治疗吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160412/IMG570C62AB017373724.jpg, createdBy=f6b41705718, createdName=Wechat4343a314, createdTime=Sat Apr 16 19:50:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78754, encodeId=54a3e8754ba, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sat Apr 16 17:30:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78755, encodeId=5655e8755e3, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sat Apr 16 17:30:00 CST 2016, time=2016-04-16, status=1, ipAttribution=)]
    2016-04-16 Wechat4343a314

    能生物治疗吗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1725136, encodeId=ebcf1e2513609, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Apr 25 10:47:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444144, encodeId=99a71444144fe, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sun Apr 17 09:47:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570735, encodeId=595315e0735b5, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Sun Apr 17 09:47:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78785, encodeId=f9bbe8785a2, content=能生物治疗吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160412/IMG570C62AB017373724.jpg, createdBy=f6b41705718, createdName=Wechat4343a314, createdTime=Sat Apr 16 19:50:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78754, encodeId=54a3e8754ba, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sat Apr 16 17:30:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78755, encodeId=5655e8755e3, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sat Apr 16 17:30:00 CST 2016, time=2016-04-16, status=1, ipAttribution=)]
    2016-04-16 李继凯

    文章不错

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1725136, encodeId=ebcf1e2513609, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60212, encryptionId=58476021257, topicName=曙光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=180c33737541, createdName=yangpeizhi, createdTime=Mon Apr 25 10:47:00 CST 2016, time=2016-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444144, encodeId=99a71444144fe, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sun Apr 17 09:47:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570735, encodeId=595315e0735b5, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Sun Apr 17 09:47:00 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78785, encodeId=f9bbe8785a2, content=能生物治疗吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160412/IMG570C62AB017373724.jpg, createdBy=f6b41705718, createdName=Wechat4343a314, createdTime=Sat Apr 16 19:50:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78754, encodeId=54a3e8754ba, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sat Apr 16 17:30:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78755, encodeId=5655e8755e3, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Sat Apr 16 17:30:00 CST 2016, time=2016-04-16, status=1, ipAttribution=)]
    2016-04-16 李继凯

    值得关注

    0

相关资讯

盘点:肿瘤免疫治疗那些事儿

Nano Lett:微针头贴片助力肿瘤免疫治疗 有效杀伤黑色素瘤近日,美国北卡罗来纳州立大学和北卡罗来纳大学教堂山分校从事生物医学工程研究的科学家们开发出一种新技术,利用嵌入微针头的贴片直接将肿瘤免疫治疗药物送达黑色素瘤位点。研究结果表明,相比于其它方法该技术能够更加有效地靶向黑色素瘤。相关研究结果发表在国际学术期刊NanoLetters上。目前癌症免疫治疗研究主要着重于使用anti-PD-1抗体

中国科大发明肿瘤化疗疗效评价成像新方法

近日,中国科学技术大学化学与材料科学学院梁高林教授课题组与中科院强磁场科学中心钟凯研究员课题组合作,发明一种能在化疗肿瘤内“智能”自聚集的磁共振纳米造影剂,并在患肿瘤的小鼠体内验证了其优异肿瘤成像效果。该研究成果3月31日在线发表在国际著名学术期刊《纳米快报》上。 半胱天冬酶家族在介导细胞凋亡的过程中起着重要的作用,对半胱天冬酶的检测可以很好地监测肿瘤细胞的早期凋亡,从而评价肿瘤化疗的疗效

3D打印技术用于治疗肿瘤,精准进行碘粒子植入

东南大学附属中大医院介入与血管外科郭金和教授团队,在为肿瘤患者施行碘粒子介入治疗时,首次用上了3D打印模板技术,2位接受这一新型组合技术治疗的患者,不仅手术时间明显缩短、痛苦减少,而且治疗的精准度显著提高。据介绍,72岁的赵大爷食管癌术后4年,最近出现进食困难、吞咽吃力,并伴有呕吐恶心、腹部不适等症状,经过检查,发现赵大爷发生了肝门部淋巴结转移。另一位65岁的患者李大爷肺癌术后一个月,出现胸闷伴呼

专家:肿瘤患者的正确的营养方法

在我国,消化道恶性肿瘤中营养不良的发病率高达70%-80%。营养不良降低肿瘤治疗的有效性,增加化、放疗的毒副作用,降低病人的生活质量,缩短肿瘤病人的生存时间。那么如何对肿瘤患者进行营养筛查、评估及诊断呢?又该如何对他们进行营养教育呢? 恶性肿瘤病人中营养不良发生率高,营养不良显著地危害着病人的生存及生活质量。晚期恶性肿瘤较多出现恶病质,早在70多年前就已经引起了临床医师的注意, 但由于当时

Baidu
map
Baidu
map
Baidu
map